drugset / Trial / NCT07097727

Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella

NCT07097727

Phase 1 Completed 70 enrolled Tanta University
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of the study is to evaluate the role of addition of Acetyl cysteine in the management of VAP induced by carbapenem resistant klebsiella. The primary outcome indicator is the change in modified clinical pulmonary infection score. The secondary outcome indicator is duration of mechanical ventilation.

Timeline

Start
2023-10-30
Primary completion
2024-09-30
Completion
2024-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 600 mg Intravenous

Indications